CIK 0001870144 · <br>Emerging growth company
Cardio Diagnostics Holdings, Inc.
Sign in to watch- Ticker
- CDIO
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870925574
- Phone
- 855-226-9991
- Business address
- 311 W. SUPERIOR STREET, SUITE 444, CHICAGO, IL, 60645
- Former names
- Mana Capital Acquisition Corp.
Securities
- CDIO Common stock Nasdaq
- CDIOW Warrant Nasdaq
- PRE 14A Proxy Proxy Statement (Preliminary)
- S-1 Offering Registration Statement
- 424B3 Offering Prospectus
- 10-K Report Annual Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 8-K Event Auditor change
- 10-Q Report Quarterly Report
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
Page 11 of 15 · 296 filings